Myogenic mechanism


The myogenic mechanism is how arteries and arterioles react to an increase or decrease of blood pressure to keep the blood flow within the blood vessel constant. Myogenic response refers to a contraction initiated by the myocyte itself instead of an outside occurrence or stimulus such as nerve innervation. Most often observed in smaller resistance arteries, this 'basal' tone may be useful in the regulation of organ blood flow and peripheral resistance, as it positions a vessel in a preconstricted state that allows other factors to induce additional constriction or dilation to increase or decrease blood flow.
The smooth muscle of the blood vessels reacts to the stretching of the muscle by opening ion channels, which cause the muscle to depolarize, leading to muscle contraction. This significantly reduces the volume of blood able to pass through the lumen, which reduces blood flow through the blood vessel. Alternatively when the smooth muscle in the blood vessel relaxes, the ion channels close, resulting in vasodilation of the blood vessel; this increases the rate of flow through the lumen.
This system is especially significant in the kidneys, where the glomerular filtration rate is particularly sensitive to changes in blood pressure. However, with the aid of the myogenic mechanism, the glomerular filtration rate remains very insensitive to changes in human blood pressure.
Myogenic mechanisms in the kidney are part of the autoregulation mechanism which maintains a constant renal blood flow at varying arterial pressure. Concomitant autoregulation of glomerular pressure and filtration indicates regulation of preglomerular resistance. Model and experimental studies were performed to evaluate two mechanisms in the kidney, myogenic response and tubuloglomerular feedback. A mathematical model showed good autoregulation through a myogenic response, aimed at maintaining a constant wall tension in each segment of the preglomerular vessels. Tubuloglomerular feedback gave rather poor autoregulation. The myogenic mechanism showed 'descending' resistance changes, starting in the larger arteries, and successively affecting downstream preglomerular vessels at increasing arterial pressures. This finding was supported by micropuncture measurements of pressure in the terminal interlobular arteries. Evidence that the mechanism was myogenic was obtained by exposing the kidney to a subatmospheric pressure of 40 mmHg; this led to an immediate increase in renal resistance, which could not be prevented by denervation or various blocking agents.

Bayliss effect

Bayliss effect or Bayliss myogenic response is a special manifestation of the myogenic tone in the vasculature. The Bayliss effect in vascular smooth muscles cells is a response to stretch. This is especially relevant in arterioles of the body. When blood pressure is increased in the blood vessels and the blood vessels distend, they react with a constriction; this is the Bayliss effect. Stretch of the muscle membrane opens a stretch-activated ion channel. The cells then become depolarized and this results in a Ca2+ signal and triggers muscle contraction. It is important to understand that no action potential is necessary here; the level of entered calcium affects the level of contraction proportionally and causes tonic contraction. The contracted state of the smooth muscle depends on the grade of stretch and plays an important part in the regulation of blood flow.
Increased contraction increases the total peripheral resistance and this further increases the mean arterial pressure. This is explained by the following equation:
, where CO is the cardiac output, which is the volume of blood pumped by the heart in one minute.
This effect is independent of nervous mechanisms, which is controlled by the sympathetic nervous system.
The overall effect of the myogenic response is to decrease blood flow across a vessel after an increase in blood pressure.

History

The Bayliss effect was discovered by physiologist Sir William Bayliss in 1902.

Proposed mechanism

When the endothelial cell in the tunica intima of an artery is stretched it is likely that the endothelial cell may signal constriction to the muscle cell layer in a paracrine fashion. Increase in blood pressure may cause depolarisation of the affected myocytes as well or endothelial cells alone. The mechanism is not yet completely understood, but studies have shown that volume regulated chloride channels and stretch sensitive non-selective cation channels lead to an increased probability in opening of L-type Ca2+ channels, thus raising the cytosolic concentration of Ca2+ leading to a contraction of the myocyte, and this may involve other channels in the endothelia.

Unstable Membrane Potentials

Many cells have resting membrane potentials that are unstable. It is usually due to ion channels in the cell membrane that spontaneously open and close. When the membrane potential reaches depolarization threshold an action potential is fired, excitation-contraction coupling initiates and the myocyte contracts.

Slow wave potentials

Slow wave potential are unstable resting membrane potentials that continuously cycle through depolarization- and repolarization phases. However, not every cycle reaches depolarization threshold and thus an action potential will not always fire. Owing to temporal summation, however, cell membrane depolarization will periodically reach depolarization threshold and an action potential will fire, triggering contraction of the myocyte.

Pacemaker potentials

Pacemaker potentials are unstable cell membrane potentials that reach depolarization threshold with every depolarization/repolarization cycle. This results in AP's being fired according to a set rhythm. Cardiac pacemaker cells, a type of cardiac myocyte in the SA node of heart, are an example of cells with a pacemaker potential.

Stretch

This mechanism involves the opening of mechanically-gated Ca2+ channels when some myocytes are stretched. The resulting influx of Ca2+ ions lead to the initiation of excitation-contraction coupling and thus contraction of the myocyte.